Skip to main content
. 2017 Feb 9;2(3):e91001. doi: 10.1172/jci.insight.91001

Figure 6. Adipocyte Jak2 mediates insulin-induced hepatic AKT activation.

Figure 6

(A) Western blot of insulin-stimulated liver lysates with antibodies against phosphorylated AKT (pAKT) and total AKT (AKT) in control (CON) and JAK2A mice following continuous delivery of vehicle (–) or recombinant growth hormone (GH, +) for 28 days. (B) Densitometric arbitrary units ratio of pAKT/AKT in control and JAK2A mice treated (GH) or not (Veh) with GH. **P < 0.01 by 1-way ANOVA. Data represent ± SEM.